Thailand, Philippines signs supply deals for AstraZeneca coronavirus vaccine, Malaysia likes Pfizer
It is expected to be delivered in mid 2021.
Thailand’s National Vaccine Institute signed a non refundable advance market commitment contract worth 2.38 billion baht ($79 million) with AstraZeneca to reserve the supply of the vaccine candidate.
Another 3.67 billion baht ($121 million) agreement for the purchase of the trial vaccine, known as AZD1222, was signed by the Health Ministry’s Disease Control Department.
Malaysia is expected to receive its first coronavirus vaccines from Pfizer in the first quarter of 2021 after signing a deal for 12.8 million doses from the U.S. manufacturer, Prime Minister Muhyiddin Yassin said on Friday.
Pfizer has agreed to deliver the first one million doses in the first quarter of 2021, with 1.7 million doses and 4.3 million to follow in subsequent quarters, Muhyiddin said.
The Philippines will get 2.6 million shots of a potential coronavirus vaccine developed by AstraZeneca under the country's first supply deal for a coronavirus vaccine, senior officials said on Friday.
This supply, to be paid for by the private sector, will inoculate just over 1 million Filipinos as the British drugmaker's vaccine requires two doses, said Jose Concepcion, a government business adviser representing the private sector. ■